Menu

Children Receive Bespoke, Lab-Grown Ears

The tissue, grown on a 3-D scaffold and seeded from the kids’ own cells, was transplanted to correct deformities in their cartilage.

Jan 30, 2018
Kerry Grens

G. SHOU ET AL., EBIOMEDICINE, DOI:10.1016/J.EBIOME.2018.01.011, 2018Five children have had ear reconstruction using lab-grown cartilage that was seeded from their own cells and grown on 3-D-printed molds, researchers reported in EBioMedicine earlier this month (January 12).

“It’s a very exciting approach,” Tessa Hadlock at the Massachusetts Eye and Ear Infirmary in Boston tells New Scientist. “They’ve shown that it is possible to get close to restoring the ear structure.”

The kids were between the ages of 6 and 10 years old and all had microtia, a malformation of the external ear. The researchers took a sample of cartilage from each child, harvested the cartilage-forming cells (called chondrocytes), expanded them, and then grew them on a mold that was build from a CT scan of the patient’s normal ear. The tissue was then implanted into a skin flap to reconstruct the ear, a process that all told took several months.

The first child has been followed for two and a half years, and the authors reported in their study that they are happy with the results, having “achieved satisfactory aesthetical outcome with mature cartilage formation.”

“The delivery of shaped cartilage for the reconstruction of microtia has been a goal of the tissue engineering community for more than two decades,” Lawrence Bonassar of Cornell University tells CNN. “This work clearly shows tissue engineering approaches for reconstruction of the ear and other cartilaginous tissues will become a clinical reality very soon.”

Previously, scientists had been able to transplant human ears into mice. Bonassar tells CNN that the challenges to expanding the use of the technique in humans include regulatory oversight and scaling up the personalized process.  

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
DeNovoMAX - NRGene's new genomics tool to meet a major agbio need:
NRGene has launched a new product that aims to empower breeding and maximize agricultural yield as part of the Denovo assembly product suite offered by the company.
Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.